Evidence map›Paper›PMID 30425531›Full record

ArticleOncoTargets and therapy2018

Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer.

Han Yu, Weiyuan Wei, Wenlong Cao, Zexu Zhan, Linhai Yan, Kun Wu, Dongyi Xie, Bin Cai, Yubo Xie, Qiang Xiao

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Han YuDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Weiyuan WeiDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Wenlong CaoDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Zexu ZhanDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Linhai YanDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Kun WuDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Dongyi XieDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Bin CaiDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
Yubo XieDepartment of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xieyubo715001@aliyun.com.
Qiang XiaoDepartment of Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, xiaoqiang20050@aliyun.com.
First Affiliated Hospital of GuangXi Medical University · CNTumor Hospital of Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroRNA (miRNA) array analysis has reported that the expression of miR-593-5p is associated with lymph node metastasis in gastric cancer (GC); however, the function and mechanism of miR-593-5p in GC have not been described yet. miR-593-5p has also not been elucidated widely in other cancers.

methodsmiR-593-5p expression was detected by quantitative RT-PCR (qRT-PCR) in human GC tissues and cell lines. Cell proliferation was investigated using CCK-8 assays, cell cycle was detected by flow cytometric method, and cell migration and invasion abilities were evaluated by wound-healing and transwell assays. miR-593-5p-influenced gene expression profiles were detected by total gene expression chip method in MGC-803 cells, and miR-593-5p candidate target genes were predicted using bioinformatics methods. The candidate target gene and downstream of miR-593-5p were determined by qRT-PCR, Western blot, and dual-luciferase reporter assays. The effects of miR-593-5p on the growth and metastasis of GC were evaluated by tumor xenograft experiment in vivo.

resultsmiR-593-5p was frequently downregulated in GC patients and GC cell lines. miR-593-5p was significantly correlated with tumor size and distant metastasis in GC patients. miR-593-5p inhibited cell proliferation, migration, and invasion and also arrested cell cycle at the G0/G1 phase in SGC-7901 and MGC-803 cells in vitro. miR-593-5p also suppressed tumor growth and metastasis in vivo. miR-593-5p influenced gene expression profile in MGC-803 cells. MST4 was indirectly targeted by miR-593-5p. miR-593-5p also downregulated FAK, MMP12, and JUN protein expression.

conclusionOur study suggests that miR-593-5p may function as a tumor suppressor in GC through a mechanism that regulates JUN pathway via indirectly targeting the MST4 gene.

Indexed as

gastric cancerJUN pathwaymiR-593-5pMST4

Identifiers

PMID30425531
PMCPMC6204852
OpenAlexW2897899285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.